Supporting agencies: The study was funded by the RFBR grant 18-07-01022.
For citations:
Lila A.M., Torshin I.Yu., Gromova O.A. Is it worthwhile rethinking the positive experience of the last 50 years of using chondroitin sulfates against atherosclerosis? FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology. 2020;13(2):184-191. (In Russ.) https://doi.org/10.17749/2070-4909/farmakoekonomika.2020.043
Views: 602
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Email this article 